Chapman, Alec B.
Peterson, Kelly S.
Alba, Patrick R.
DuVall, Scott L.
Patterson, Olga V. http://orcid.org/0000-0002-8717-5975
Funding for this research was provided by:
VA HSR (VA HSR RES 13-457)
Article History
First Online: 16 January 2019
Compliance with Ethical Standards
:
: The work described in the manuscript was supported using resources and facilities at the VA Salt Lake City Health Care System. The work in part was funded by VA Informatics and Computing Infrastructure (VINCI), VA HSR HIR 08-204.
: Olga V. Patterson reports grants from National Heart, Lung, and Blood Institute, Department of Defense, Amgen Inc., Anolinx LLC, Genentech Inc., Gilead Sciences Inc., Merck & Co., Inc., Novartis International AG, and PAREXEL International Corporation outside the submitted work. Scott L. DuVall reports grants from National Heart, Lung, and Blood Institute during the conduct of the study; and grants from AbbVie Inc., Amgen Inc., Anolinx LLC, Astellas Pharma Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim International GmbH, F. Hoffman-La Roche Ltd, Genentech Inc., Genomic Health, Inc., Gilead Sciences Inc., GlaxoSmithKline PLC, HITEKS Solutions Inc., Innocrin Pharmaceuticals Inc., Kantar Health, LexisNexis Risk Solutions, Merck & Co., Inc., Mylan Specialty LP, Myriad Genetics, Inc., Northrop Grumman Information Systems, Novartis International AG, PAREXEL International Corporation, and Shire PLC outside the submitted work. Alec B. Chapman, Kelly S. Peterson and Patrick R. Alba report no conflicts of interest that are directly relevant to the content of the reported study.
: The study has been approved by the University of Utah Institutional Review Board.